Amelioration of pregnancy-associated osteoporosis after treatment with vitamin K2: A report of four patients

Upsala Journal of Medical Sciences

Volumn 117, Issue 3, 2012, Pages 336-341

  Tsuchie, Hiroyuki ^a   Miyakoshi, Naohisa ^a   Hongo, Michio ^a   Kasukawa, Yuji ^a   Ishikawa, Yoshinori ^a   Shimada, Yoichi ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Pregnancy associated osteoporosis; Vertebral fracture; Vitamin K2

Indexed keywords

FARNOQUINONE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; OSTEOPOROSIS; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; FEMALE; HUMANS; OSTEOPOROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; VITAMIN K 2;

EID: 84864867332     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009734.2012.676573     Document Type: Article

References (14)

1. Nordin BE, Roper A. Post-pregnancy osteoporosis; a syndrome? Lancet. 1955;268:431-4.
2. VanHouten JN, Wysolmerski JJ. Low estrogen and high parathyroid hormone-related peptide levels contribute to accere-lated bone resorption and bone loss in lactating mice. Endcrinology. 2003;144:5521-9.
3. Sowers MF, Hollis BW, Shapiro B, Randolph J, Janney CA, Zhang D, et al. Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA. 1996; 276:549-54.
4. Kaur M, Pearson D, Godber I, Lawson N, Baker P, Hosking D. Longitudinal changes in bone mineral density during normal pregnancy. Bone. 2003;32:449-54.
5. Rizzoli R, Bonjour JP. Pregnancy-associated osteoporosis. Lancet. 1996;347:1274-5.
6. Dunne F, Walters B, Marshall T, Heath DA. Pregnancy associated osteoporosis. Clin Endocrinol (Oxf). 1993;39:487.
7. Yamaga A, Taga M, Takahashi T, Shirai T. A case of post-pregnancy osteoporosis. Eur J Obstet Gynecol Reprod Biol. 2000;88:107-9.
8. Anai T, Tomiyasu T, Arima K, Miyakawa I. Pregnancy-associated osteoporosis with elevated levels of circulating parathyroid hormone-related protein: a report of two cases. J Obstet Gynaecol Res. 1999;25:63-7.
9. Shearer MJ. Vitamin K. Lancet. 1995;345:229-34.
10. 2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem. 2003;278:43919-27.
11. Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2 (mena-tetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res. 2000; 15:515-21.
12. Bayram S, Ozturk C, Sivrioglu K, Aydini U, Kucukoglu S. Kyphoplasty for pregnancy-associated osteoporotic vertebral fractures. Joint Bone Spine. 2006;73:564-6.
13. Bone HG, Hosking D, Devogelaer J, Tucci JR, Emkey RD, Tonino RP, et al. Alendronate Phase III Osteoporosis Treatment Study Group. Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med. 2004;350:1189-99.
14. Shimada H, Himeno K, Michimoto T, Tanada S, Ikeuchi M, Ono Y, et al. Prevention of vitamin K deficiency in the early period\prophylactic oral administration of VK to the mother. Nihon Sanka Fujinka Gakkai Zasshi. 1990;42:705-10; in Japanese.